digestive/alimentary system
• appearance of severe diarrhea and rectal bleeding in mice given tamoxifen is followed by death within 24 hours
|
• appearance of severe diarrhea and rectal bleeding in mice given tamoxifen is followed by death within 24 hours
|
• wide gaps in epithelial tight junctions found in enterocytes following tamoxifen administration
|
• loss of most epithelial cells in large intestine following tamoxifen administration
• remaining mucosa is infiltrated with inflammatory and immune cells
• intestinal barrier disruption observed as early as 24 hours after tamoxifen treatment
|
• unrecognizable crypt structures in large intestine by day 5 following tamoxifen administration
|
• mice develop severe colitis following tamoxifen administration
• loss of most epithelial cells in large intestine following tamoxifen administration
• remaining mucosa is infiltrated with inflammatory and immune cells
|
• inflammation in small and large intestines following tamoxifen administration
|
cellular
• more than 2 centrosomes observed in enterocytes following tamoxifen administration
|
• mitosis is abnormally prolonged in enterocytes following tamoxifen administration
|
• mitotic enterocytes have abnormal spindles following tamoxifen administration
|
• observed in enterocytes following tamoxifen administration
|
cardiovascular system
• appearance of severe diarrhea and rectal bleeding in mice given tamoxifen is followed by death within 24 hours
|
endocrine/exocrine glands
• unrecognizable crypt structures in large intestine by day 5 following tamoxifen administration
|
homeostasis/metabolism
• increase in IL1b levels beginning day 1 and spiking on day 3 following tamoxifen administration
|
immune system
• inflammation in small and large intestines following tamoxifen administration
|
• increase in IL1b levels beginning day 1 and spiking on day 3 following tamoxifen administration
|
mortality/aging
• appearance of severe diarrhea and rectal bleeding in mice given tamoxifen is followed by death within 24 hours
|